These findings were strongly supported by the observation that LYN expression was significantly enhanced in lymph node fibroblasts of CLL patients compared to healthy controls, accompanied by lower levels of fibroblastic THBS1 in CLL than healthy controls. This evidence concerns the gene THBS1 and B-cell chronic lymphocytic leukemia.